Table 1 Baseline characteristics
From: Clinical results after hybrid coronary revascularization with totally endoscopic coronary surgery
Unmatched patients | Matched patients | ||||
|---|---|---|---|---|---|
HCR (N = 103) | Endo-CABG (N = 244) | p value | Endo-CABG (N = 103) | p value | |
Age (years) | 65.23 ± 9.96 | 67.67 ± 10.15 | 0.040 | 65.72 ± 9.61 | 0.722 |
Octogenarians | 8 (7.77) | 34 (13.93) | 0.107 | 7 (6.80) | 0.789 |
Gender (male) | 88 (85.44) | 207 (84.84) | 0.886 | 89 (86.41) | 0.841 |
BMI (kg/m2) | 27.94 ± 4.18 | 27.74 ± 4.31 | 0.680 | 28.10 ± 4.08 | 0.781 |
EuroSCORE II | 2.24 ± 2.60 | 2.78 ± 2.97 | 0.243 | 2.41 ± 3.02 | 0.895 |
NYHA | 0.192 | 0.225 | |||
I | 62 (60.19) | 123 (50.41) | 50 (48.54) | ||
II | 35 (33.98) | 94 (38.52) | 43 (41.75) | ||
III | 4 (3.88) | 24 (9.84) | 9 (8.74) | ||
IV | 2 (1.94) | 2 (0.82) | 1 (0.97) | ||
LVEF (%) | 56.24 ± 9.62 | 55.81 ± 11.71 | 0.782 | 56.84 ± 13.09 | 0.770 |
Comorbidities | |||||
Smoking | 22 (21.36) | 69 (28.28) | 0.327 | 29 (28.16) | 0.520 |
DM type I | 0 | 2 (0.82) | 0.628 | 0 | 0.656 |
DM type II | 32 (31.07) | 79 (32.38) | 35 (33.98) | ||
Atrial hypertension | 66 (64.07) | 159 (65.16) | 0.847 | 68 (66.02) | 0.770 |
Dyslipidemia | 89 (86.41) | 200 (81.97) | 0.311 | 85 (82.52) | 0.442 |
Family cardiac history | 52 (50.49) | 120 (49.18) | 0.664 | 58 (56.31) | 0.552 |
Extracardiac arteriopathy | 15 (14.56) | 44 (18.03) | 0.432 | 19 (18.45) | 0.453 |
Atrial fibrillation | 9 (8.74) | 25 (10.25) | 0.666 | 11 (10.68) | 0.638 |
Pacemaker | 1 (0.97) | 8 (3.29) | 0.193 | 3 (2.91) | 0.360 |
Chronic kidney disease | 11 (10.68) | 49 (20.08) | 0.034 | 14 (13.59) | 0.522 |
Previous PCI | 18 (17.48) | 72 (29.51) | 0.020 | 18 (17.48) | 0.856 |
Previous cardiac surgery | 2 (1.94) | 3 (1.23) | 0.611 | 1 (0.97) | 0.561 |
Neurological history | 0.360 | 0.241 | |||
CVA | 2 (1.94) | 16 (6.56) | 7 (6.80) | ||
TIA | 3 (2.91) | 6 (2.46) | 1 (0.97) | ||
Left main disease | 18 (17.48) | 87 (35.66) | < 0.001 | 23 (13.59) | 0.383 |